Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
307.10
+3.55 (1.17%)
At close: Aug 8, 2025, 4:00 PM
305.00
-2.10 (-0.68%)
After-hours: Aug 8, 2025, 5:23 PM EDT
Chuy's Holdings Employees
Insulet had 3,900 employees as of December 31, 2024. The number of employees increased by 900 or 30.00% compared to the previous year.
Employees
3,900
Change (1Y)
900
Growth (1Y)
30.00%
Revenue / Employee
$605,000
Profits / Employee
$60,538
Market Cap
21.62B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3,900 | 900 | 30.00% |
Dec 31, 2023 | 3,000 | 400 | 15.38% |
Dec 31, 2022 | 2,600 | 300 | 13.04% |
Dec 31, 2021 | 2,300 | 400 | 21.05% |
Dec 31, 2020 | 1,900 | 550 | 40.74% |
Dec 31, 2019 | 1,350 | 181 | 15.48% |
Dec 31, 2018 | 1,169 | 312 | 36.41% |
Dec 31, 2017 | 857 | 217 | 33.91% |
Dec 31, 2016 | 640 | -7 | -1.08% |
Dec 31, 2015 | 647 | 128 | 24.66% |
Dec 31, 2014 | 519 | 41 | 8.58% |
Dec 31, 2013 | 478 | -60 | -11.15% |
Dec 31, 2012 | 538 | -38 | -6.60% |
Dec 31, 2011 | 576 | 266 | 85.81% |
Dec 31, 2010 | 310 | 34 | 12.32% |
Dec 31, 2009 | 276 | -18 | -6.12% |
Dec 31, 2008 | 294 | 47 | 19.03% |
Dec 31, 2007 | 247 | -47 | -15.99% |
Dec 31, 2006 | 294 | 47 | 19.03% |
Dec 31, 2005 | 247 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PODD News
- 1 day ago - Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5 - Benzinga
- 1 day ago - Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Insulet beats second-quarter profit estimates on strong demand for insulin pumps - Reuters
- 2 days ago - Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1) - Business Wire
- 8 days ago - 10 stocks favored to gain up to 30% in a sector that has missed this year's rally - Market Watch
- 18 days ago - 15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them - Market Watch
- 4 weeks ago - Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025 - Business Wire
- 7 weeks ago - Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions - Business Wire